Back to results
RecruitingPhase 3

Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

NCT07062198

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Department of Neurology and Neuroscience, Faculty of Medicine, Alaaddin Keykubat University

Alanya, Turkey (Türkiye)

+7 additional locations

Contact

Sevki SAHIN, Prof. Dr.

+90 216 606 33 00drsahin@gmail.com
View on ClinicalTrials.gov
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease — TrialFind